Literature DB >> 26125435

Clinicopathologic Correlates of Primary Aldosteronism.

Kai Duan, Ozgur Mete1.   

Abstract

Primary aldosteronism is the most common cause of secondary hypertension, incurring significant cardiovascular morbidity and mortality. Our understanding of this disease has evolved substantially during the past decade. Recently, the molecular basis of primary aldosteronism has begun to be unraveled, with the discovery of mutations in potassium channel (KCNJ5), ATPases (ATP1A1, ATP2B3), and calcium channel (CACNA1D), and aberrant Wnt/β-catenin signaling. The most recent data suggest that 95% of cases are sporadic, whereas 5% of cases are hereditary. Pathologic correlates of primary aldosteronism include adrenal cortical hyperplasia, adenoma, and carcinoma. Although the most common clinical presentation is bilateral adrenal cortical hyperplasia, this entity is usually treated medically. Therefore, in the setting of primary aldosteronism, surgical pathologists are most commonly exposed to adrenocortical adenomas and the odd occasional carcinoma. This review provides an update on the current knowledge of primary aldosteronism and discusses the clinicopathologic correlations of this important disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26125435     DOI: 10.5858/arpa.2014-0156-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

Review 1.  What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics.

Authors:  C Christofer Juhlin; Ozgur Mete; Jérôme Bertherat; Thomas J Giordano; Gary D Hammer; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2021-02-03       Impact factor: 3.943

Review 2.  Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms.

Authors:  Ozgur Mete; Sylvia L Asa; Thomas J Giordano; Mauro Papotti; Hironobu Sasano; Marco Volante
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

3.  Hypokalemic Paralysis Complicated by Concurrent Hyperthyroidism and Hyperaldosternoism: A Case Report.

Authors:  Yu-Hsin Hsiao; Yu-Wei Fang; Jyh-Gang Leu; Ming-Hsein Tsai
Journal:  Am J Case Rep       Date:  2017-01-04

Review 4.  The Many Faces of Primary Aldosteronism and Cushing Syndrome: A Reflection of Adrenocortical Tumor Heterogeneity.

Authors:  Ozgur Mete; Kai Duan
Journal:  Front Med (Lausanne)       Date:  2018-03-12

Review 5.  Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.

Authors:  Ozgur Mete; Lori A Erickson; C Christofer Juhlin; Ronald R de Krijger; Hironobu Sasano; Marco Volante; Mauro G Papotti
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 4.056

Review 6.  Disorders of the adrenal cortex: Genetic and molecular aspects.

Authors:  Georgia Pitsava; Andrea G Maria; Fabio R Faucz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-29       Impact factor: 6.055

Review 7.  The Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence.

Authors:  Paula F Kinoshita; Jacqueline A Leite; Ana Maria M Orellana; Andrea R Vasconcelos; Luis E M Quintas; Elisa M Kawamoto; Cristoforo Scavone
Journal:  Front Physiol       Date:  2016-06-02       Impact factor: 4.566

Review 8.  Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism.

Authors:  Nada El Ghorayeb; Isabelle Bourdeau; André Lacroix
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-27       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.